产品详情
Targets
Target | Value | |
---|---|---|
Kit | ||
FLT3 | ||
PDGFRβ | IC50: 2nM | |
VEGFR2 | IC50: 80nM | |
FGFR1 | IC50: 2.9μM | |
EGFR | IC50: >20μM |
In vitro (25°C) | DMSO | 13 mg/mL (24.41 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 4% DMSO+30% PEG 300+ddH2O | 1 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.78 mL | 93.88 mL | 187.76 mL |
0.5 mM | 3.76 mL | 18.78 mL | 37.55 mL |
1 mM | 1.88 mL | 9.39 mL | 18.78 mL |
5 mM | 0.38 mL | 1.88 mL | 3.76 mL |
*The above data is based on the productmolecular weight 532.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10880 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 532.6 |
Formula | C22H27FN4O2.C4H6O5 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 341031-54-7 |
Synonyms | SU-11248 |
SMILES | CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C.C([C@@H](C(=O)O)O)C(=O)O |
产品标签
Product Questions
Product Questions
Flumatinib mesylate
Flumatinib mesylate以时间和剂量依赖性的方式降低U266细胞中C-MYC,HIF-1a和VEGF的表达,因此甲磺酸氟马替尼可能…
BGJ398 (NVP-BGJ398)
BGJ398 (NVP-BGJ398)是一种有效的选择性抑制剂,具有成纤维细胞生长因子受体(FGFR)酪氨酸激酶1、2、3和4的…
Toceranib (PHA 291639, SU 11654)
Toceranib (PHA 291639,SU 11654)是一种激酶抑制剂,通过抑制KIT,血管内皮生长因子受体2和PDGFRβ同时具有抗肿瘤…
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
AC710 Mesylate
AC710 Mesylate是一种有效的选择性PDGFR家族激酶抑制剂,对于FLT3/KIT/PDGFRα/PDGFRβ的Kd值分别为0.6 nM/1.0 nM/1.3 nM/1.…
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种…